
Virology Specimen Collection Market Report 2026
Global Outlook – By Product Type (Blood Collection Kits, Specimen Collection Tubes, Viral Transport Media, Swabs ), By Sample (Blood Samples, Nasopharyngeal Samples, Throat Samples, Nasal Samples, Cervical Samples, Oral Samples, Other Samples ), By Method (Manual, Automated ), By Application (Diagnostic, Therapeutic) - Market Size, Trends, And Global Forecast 2026-2035
Virology Specimen Collection Market Overview
• Virology Specimen Collection market size has reached to $6.96 billion in 2025 • Expected to grow to $9.22 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Growth In Blood Donations Driving Demand For Virology Specimen Collection • Market Trend: Technological Advancements Shaping Virology Specimen Collection Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Virology Specimen Collection Market?
A virology specimen is a blood sample taken for examination of specimens in order to look for any type of infection. The virus isolation specimens should be collected within four days of the onset of sickness, as virus shedding reduces significantly after that. Virus cultures are not useful for specimens taken more than 7 days after the onset of sickness, with a few exceptions to be used by government health authorities, hospitals, clinicians, and laboratories that are collecting relevant clinical samples for diagnosis. The main types of virology specimen collection are blood collection kits, specimen collection tubes, viral transport media, and swabs. The vials and reagents given for use in collecting samples and transporting them to the laboratory where the testing services would be performed on such samples are referred to as the sample collection kit. Virology specimen collection samples can be blood samples, nasopharyngeal samples, throat samples, nasal samples, cervical samples, oral samples, and other samples that were taken manually or automated that can be used in diagnostic, and therapeutic.
What Is The Virology Specimen Collection Market Size and Share 2026?
The virology specimen collection market size has grown strongly in recent years. It will grow from $6.96 billion in 2025 to $7.39 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to expansion of infectious disease testing programs, increased hospital diagnostic volumes, rising awareness of early viral detection, growth of centralized laboratory testing, standardization of clinical sampling protocols.What Is The Virology Specimen Collection Market Growth Forecast?
The virology specimen collection market size is expected to see strong growth in the next few years. It will grow to $9.22 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising adoption of home-based sample collection, expansion of surveillance testing programs, growing investments in laboratory automation, increasing focus on rapid diagnostic turnaround. Major trends in the forecast period include increasing demand for standardized specimen collection kits, rising use of viral transport media, growing adoption of automated sample handling, expansion of point-of-care collection solutions, enhanced focus on sample integrity and stability.Global Virology Specimen Collection Market Segmentation
1) By Product Type: Blood Collection Kits, Specimen Collection Tubes, Viral Transport Media, Swabs 2) By Sample: Blood Samples, Nasopharyngeal Samples, Throat Samples, Nasal Samples, Cervical Samples, Oral Samples, Other Samples 3) By Method: Manual, Automated 4) By Application: Diagnostic, Therapeutic Subsegments: 1) By Blood Collection Kits: Vacuum Blood Collection Tubes, Syringe Blood Collection Kits 2) By Specimen Collection Tubes: EDTA Tubes, Serum Separation Tubes, Heparin Tubes 3) By Viral Transport Media: Liquid Media, Dry Media 4) By Swabs: Nasopharyngeal Swabs, Oropharyngeal Swabs, Urethral SwabsWhat Is The Driver Of The Virology Specimen Collection Market?
The growing number of blood donations is driving the growth of the virology specimen collection market. With the growing number of blood samples, there is a rise in the examination and detection of viruses in the blood using the virology specimen collection method. For instance, in June 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, about 118.54 million blood donations were collected worldwide. 40% of these were collected in high-income countries, which is around 16% of the world's population. About 13,300 blood centers in 169 countries report collecting a total of 106 million donations. Therefore, demand for virology specimen collection is predicted to rise as the prevalence of increase in the number of blood donations.Key Players In The Global Virology Specimen Collection Market
Major companies operating in the virology specimen collection market are Puritan Medical Products Co. LLC, Becton Dickinson and Company, Quidel Corporation, Trinity Biotech plc, DiaSorin S.p.A., Vircell S.L., Copan Italia S.p.A., Hardy Diagnostics, Laboratory Corporation of America Holdings, ZeptoMetrix Corporation, Copan Diagnostics Inc., Bionote Inc., F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., Hologic Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GenMark Diagnostics Inc., Luminex Corporation, Abbott Laboratories, BioFire Diagnostics LLC, Randox Laboratories Ltd., Savyon Diagnostics Ltd., Seegene Inc., Serosep Ltd., SolGent Co. Ltd., TECOmedical AG, Vela Diagnostics, Zybio Inc.Global Virology Specimen Collection Market Trends and Insights
Major companies operating in the market are focusing on developing innovative solutions such as automated sample isolation and real-time amplification technologies to enhance diagnostic accuracy and provide clinically relevant information for optimal antiviral treatments. Automated sample isolation and real-time amplification technologies allow for faster and more precise identification of clinically relevant viruses, enabling healthcare providers to tailor antiviral therapies and improve patient outcomes. For instance, in August 2023, Nightingale Health Plc, a Finland-based health technology company, launched a remote blood collection kit for its medical research and clinical trial customers. Using the Nightingale Kit and its self-collection tool, research participants can prick their own finger to obtain their own blood sample. This greatly increases flexibility and opens up study options that were previously restricted by logistical and geographic constraints. Additionally, remote blood collection may be seamlessly and affordably incorporated into research because Nightingale Health offers both sample collection and sample analysis.What Are Latest Mergers And Acquisitions In The Virology Specimen Collection Market?
In April 2024, Eurofins Scientific, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed sum. This acquisition is a strategic move that enables Eurofins to enhance its diagnostic services, particularly for patients with kidney disease and those requiring transplant care. With the growing demand for specialized healthcare solutions, this addition is particularly timely. Ascend Clinical is a US-based clinical testing services provider specifically to the needs of renal patients.Regional Outlook
North America was the largest region in the virology specimen collection market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Virology Specimen Collection Market?
The virology specimen market consists of sales of conjunctiva (eye) swab, cerebral spinal fluid (csf), lesions, tissue specimens, and bone marrow. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Virology Specimen Collection Market Report 2026?
The virology specimen collection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the virology specimen collection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Virology Specimen Collection Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.39 billion |
| Revenue Forecast In 2035 | $9.22 billion |
| Growth Rate | CAGR of 6.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Sample, Method, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Puritan Medical Products Co. LLC, Becton Dickinson and Company, Quidel Corporation, Trinity Biotech plc, DiaSorin S.p.A., Vircell S.L., Copan Italia S.p.A., Hardy Diagnostics, Laboratory Corporation of America Holdings, ZeptoMetrix Corporation, Copan Diagnostics Inc., Bionote Inc., F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., Hologic Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GenMark Diagnostics Inc., Luminex Corporation, Abbott Laboratories, BioFire Diagnostics LLC, Randox Laboratories Ltd., Savyon Diagnostics Ltd., Seegene Inc., Serosep Ltd., SolGent Co. Ltd., TECOmedical AG, Vela Diagnostics, Zybio Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
